Glipizide Active Pharmaceutical Ingredient from Japan
Glipizide is an aromatic imine-function compound used as the active ingredient in oral antidiabetic medications for type 2 diabetes treatment. It falls under HTS 2925.29.20.00 as a drug classified among aromatic imines and their derivatives. This bulk API is imported for pharmaceutical formulation into tablets.
Duty Rate — Japan → United States
15%
Rate breakdown
9903.04.628.5%Patented pharmaceutical articles that are the product of Japan, of a European Union member country, of South Korea, of Switzerland, or of Liechtenstein as provided for in subdivisions (c) and (f) of U.S. note 40 to this subchapter
9903.05.900%Articles of aluminum, of steel or of copper or derivative aluminum or steel articles; passenger vehicles (sedans, sport utility vehicles, crossover utility vehicles, minivans and cargo vans) and light trucks; parts of passenger vehicles (sedans, sport utility vehicles, crossover utility vehicles, minivans and cargo vans) and light trucks; medium- and heavy-duty vehicles; parts of medium- and heavy-duty vehicles; wood products; patented pharmaceutical articles; and semiconductor articles, as provided in subdivision (f) of U.S. note 52 to this subchapter
Import Tips
• Obtain FDA Drug Master File (DMF) and ensure Certificate of Analysis meets USP standards
• Provide detailed impurity profile and stability data required for API drug imports
• Verify aromatic imine structure classification to avoid reclassification under 2933 headings